Form 4: Encompass Health EVP, Chief Operating Officer Patrick Tuer Reports Acquisition and Disposal of Shares

Sentiment:

SEC Form 4 Filing


Patrick William Tuer, EVP and Chief Operating Officer of Encompass Health Corp, reports the acquisition of 5,984 shares and disposal of shares on April 30, 2025.

Summary

  • On April 30, 2025, Patrick William Tuer, the EVP and Chief Operating Officer of Encompass Health Corp, reported a transaction involving Encompass Health Common Stock.
  • Mr. Tuer acquired 5,984 shares of Encompass Health Common Stock at a price of $0.
  • Mr. Tuer also disposed of shares.
  • Following the reported transactions, Mr. Tuer beneficially owns 19,866 shares of Encompass Health Common Stock.

Sentiment

Score: 6

Explanation: The document is a neutral regulatory filing. The sentiment is moderately positive as it reflects an executive increasing their stake in the company, which can be seen as a sign of confidence.

Positives

  • The acquisition of shares reflects an increased stake in the company by a key executive.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency regarding the alignment of executive interests with shareholder value.

Comparison to Industry Standards

  • Executive compensation packages often include stock options and restricted stock awards to incentivize performance and align executive interests with shareholder value.
  • Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency and compliance with securities regulations.
  • Companies like Select Medical Holdings Corporation (SEM) and Kindred Healthcare also regularly disclose similar transactions by their executives.

Stakeholder Impact

  • The transaction could have a minor positive impact on shareholder sentiment, as it indicates confidence from a key executive.
  • The award of restricted stock aligns the executive's interests with those of the shareholders.

Key Dates

DateDescription
2024-12-27SEC Release Nos. 33-11313; 34-101209; 39-2557; IC-35343; File No. S7-15-23
2025-04-16Date of Power of Attorney execution.
2025-04-30Date of the reported stock transaction (acquisition and disposal).
2025-05-01Date of signature for the Form 4 filing.

Keywords

Encompass Health Corp, Patrick William Tuer, EVP, Chief Operating Officer, Form 4, Beneficial Ownership, Stock Acquisition, Stock Disposal, Securities Exchange Act, Restricted Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.